Drafter: "the ann that we will never see coming but always lurks...

Drafter: "the ann that we will never see coming but always lurks is a buyout".

I think Benitec could become a takeover target due to:
- Low share price / market cap
- Valuable IP
- Big pharma searching for the next big thing
- Pfizer for one obviously concluding (as part of its due diligence before signing the Hep C deal with Tacere) that the '099 patent will be upheld

Regarding the AIDS lymphoma COH trial, would anyone care to speculate on the significance of the interim results that should be released soon?